China’s Efforts To Develop Anti-Ebola Drugs Illustrate Opportunities, Challenges In R&D, Ensuring Global Health Security

Council on Foreign Relations’ “Asia Unbound”: A Tale of Two Anti-Ebola Drugs
Yanzhong Huang, senior fellow for global health at the Council on Foreign Relations, discusses China’s experience developing experimental anti-Ebola drugs, writing, “[T]he story of China’s efforts to develop anti-Ebola drugs is illustrative of the opportunities and challenges we face in ensuring global health security. … Unfortunately, intellectual property issues remain an insurmountable hurdle for China to … serve as a real leader in [global health security]. New norms and rules will be needed to balance public health and intellectual property considerations in pursuing and promoting global health security” (6/16).